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Abstract
Problem/Condition: Since the birth of the first U.S. infant conceived with Assisted Reproductive Technology (ART) in 1981, 
use of advanced technologies to overcome the problem of infertility has increased steadily, as has the number of fertility clinics 
providing ART services in the United States. ART includes fertility treatments in which both eggs and sperm are handled in 
the laboratory (i.e., in vitro fertilization [IVF] and related procedures). Women who undergo ART procedures are more likely 
to deliver multiple-birth infants than those who conceive naturally. Multiple births pose substantial risks to both mothers and 
infants, including pregnancy complications, preterm delivery, and low birthweight infants. This report presents the most recent 
data on ART use and birth outcomes for U.S. states and territories.
Reporting Period Covered: 2009. 
Description of System: In 1996, CDC began collecting data on all ART procedures performed in the United States, as mandated 
by the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA) (Public Law 102-493 [October 24, 1992]). ART 
data for 1995–2003 were obtained from the Society of Assisted Reproductive Technology (SART) through its proprietary Clinical 
Outcomes Reporting System data base (SART CORS). Since 2004, CDC has contracted with Westat, Inc., a statistical survey 
research organization, to obtain data from fertility clinics in the United States through the National ART Surveillance System 
(NASS), a web-based data collection system developed by CDC.
Results: In 2009, a total of 146,244 ART procedures were reported to CDC. These procedures resulted in 45,870 live-birth deliveries 
and 60,190 infants. The largest numbers of ART procedures were performed among residents of California (18,405), New York 
(14,539), Illinois (10,192), Massachusetts (9,845), New Jersey (9,146), and Texas (8,244). Together, these six states reported the 
highest number of live-birth deliveries as a result of ART and accounted for 48% of all ART procedures initiated, 46% of all infants 
born from ART, and 45% of all ART multiple-birth deliveries but only 34% of all births in the United States. Nationally, the average 
number of ART procedures performed per 1 million women of reproductive age (15–44 years), which is a proxy indicator of ART 
utilization, was 2,361. In four states (Massachusetts, New York, New Jersey, and Connecticut) and the District of Columbia, this 
proxy measure of ART use exceeded twice the national average. Nationally, the average number of embryos transferred was 2.1 
among women aged <35 years, 2.5 among women aged 35–40 years, and 3.0 among women aged >40 years (and varied most in this 
age group from 1.7 in Maine to 3.5 in Missouri). Age-specific elective single-embryo transfer (eSET) rates were approximately 7% 
among women aged <35 years, 3% among women aged 35–40 years, and 0.5% among women aged >40 years. The highest rates of 
eSET were observed among women aged <35 years (41% in Delaware, 20% in Iowa, and 17% Massachusetts). 
Overall, ART contributed to 1.4% of U.S. births (ranging from 0.2% in Puerto Rico to 4.3 % in Massachusetts). The proportion 
of ART to total infants born in the state or territory, which is another measure of ART utilization, was highest in Massachusetts 
(>4%) with high rates also observed in New Jersey, New York, Connecticut, and the District of Columbia (>3% of all infants born). 
Infants conceived with ART accounted for 20% of all multiple-birth infants (ranging from 4% in Maine to 41% in New York), 19% 
of all twin births (ranging from 4% in Maine to 42% in New York) and 34% of triplet or higher order births (ranging from 0 in 
several states to 61.5% in New Jersey). Among infants conceived 
with ART, 47% were born as multiple-birth infants (ranging from 
35% in Delaware to 60.8% in Wyoming), compared with only 
3% of infants among the general birth population (ranging from 
1% in New York to 5% in Connecticut). 
Corresponding author: Saswati Sunderam, PhD, Division of 
Reproductive Health, National Center for Chronic Disease Prevention 
and Health Promotion, CDC, 1600 Clifton Road N.E., MS K-34, 
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Nationally, infants conceived with ART contributed to approximately 6% of all low birthweight (<2,500 grams) infants, ranging 
from 1.3% in Mississippi to 15% in Massachusetts and to 6% of all very low birthweight (<1,500 grams) infants, ranging from 
1% in Alaska to 15% in New Jersey. Overall, among ART-conceived infants, 32% were low birthweight (ranging from 20% in 
Alaska to 48% in Puerto Rico), compared with 8% among the general birth population (ranging from 5.8% in South Dakota 
to 12.2% in Mississippi), and 6% of ART infants were very low birthweight (ranging from 1.5% in Alaska to 13% in South 
Dakota), compared with 1% among the general birth population (ranging from 1% in Alaska to 2% in Mississippi and District of 
Columbia). Finally, ART-conceived infants accounted for 3.9% of all preterm (<37 weeks; range: 0.5% in Puerto Rico to 11.1% 
in Massachusetts) and 4.5% of all very preterm births (<32 weeks; range: 0.5% in Puerto Rico to 12% in New York). Overall, 
among infants conceived with ART, 33.4% were born preterm (ranging from 21.3% in Vermont to 47.1% in Wyoming), compared 
with 12.2% of the general birth population (ranging from 9.3% in Vermont to 18.0% in Mississippi), and 6.1% of ART infants 
were very preterm births (ranging from 1.5% in Alaska to 14.7% in South Dakota), compared with 2% among the general birth 
population (ranging from 1.4% in Alaska, Oregon, Utah, and Washington to 3% in Mississippi). 
Interpretation: The proportion of births from ART varied considerably by state and territory (ranging from 0.2% to 4.3%) 
with substantial impact on perinatal outcomes in some states. In most states, multiple births from ART accounted for substantial 
proportions of twins and triplets and higher order infants, and the rates of low birthweight and preterm births were disproportionately 
higher among ART infants than in the general birth population. More than one embryo was transferred per procedure in most 
states and territories for all age groups, influencing the overall multiple birth rates in the United States. ART use was represented 
disproportionately in the United States, with only 13 states having above-average ART use. High rates of ART utilization were 
observed in Massachusetts and New Jersey, which have comprehensive statewide-mandated health insurance coverage for ART 
procedures. Insurance mandates might influence ART utilization and ART-related birth outcomes. 
Public Health Actions: Promotion of single-embryo transfer, where feasible, is needed to reduce multiple births and related adverse 
consequences of ART. Nevertheless, because ART accounts for a relatively small fraction of total births in most states and territories, 
the overall prevalence of low birthweight and preterm births cannot be explained solely by the use of ART, and therefore non-ART 
causes of these adverse outcomes must be examined. Monitoring the use of non-ART infertility treatments (e.g., ovulation stimulation 
medications without ART) in the general population might be useful because these treatments also might be associated with high 
rates of multiple births and adverse outcomes such as preterm delivery and infants born with low birthweight. 
* Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA), Public 
Law 102-493 (October 24, 1992).
Introduction
Since the birth of the first U.S. infant conceived with 
Assisted Reproductive Technology (ART) in 1981, use of 
advanced technologies to overcome the problem of infertility 
has increased steadily, as has the number of fertility clinics 
providing ART services and procedures in the United States (1).
In 1992, Congress passed the Fertility Clinic Success Rate 
and Certification Act (FCSRCA),* which requires that all U.S. 
fertility clinics performing ART procedures report data to CDC 
annually on every ART procedure initiated. In 1997, CDC 
published the first annual ART Success Rates Report under 
FCSRCA, which reported on ART procedures performed in 
1995 (2). CDC uses the data it receives to report pregnancy 
success rates for all ART programs and clinics. Several measures 
of success for ART are presented in the annual report, including 
the percentage of ART cycles that result in a pregnancy, live-
birth deliveries, and singleton live births. The ART Success 
Rates Reports contain national summaries as well as specific 
details for each fertility clinic.
Despite its increasing use, ART is associated with potential risks 
to the mother and fetus. Multiple-infant births are associated with 
greater health problems for mothers and infants, including higher rates 
of caesarean deliveries, prematurity, low birthweight, infant death, 
and disability (3–12). In addition, concerns exist regarding elevated 
risks of birth defects, genetic abnormalities, and imprinting disorders 
(Beckwith-Wiedermann syndrome and Angelman syndrome) 
associated with infertility and infertility treatments with ART 
(13,14). Because multiple embryos are transferred in the majority of 
ART procedures, ART has been associated with a substantial risk for 
multiple-gestation pregnancy and multiple births (3–10). Further, 
even singleton infants conceived with ART have a higher risk of low 
birthweight (15,16). CDC also performs in-depth analyses of infant 
health outcomes reported by U.S. fertility clinics (1).
This report is based on ART surveillance data for procedures 
performed in 2009 that were collected by CDC’s Division of 
Reproductive Health. It presents data regarding the use of ART 
in each U.S. state and territory as well as outcomes, and examines 
the contribution of ART to selected adverse outcomes (e.g., 
multiple birth, low birthweight, and preterm delivery). A 2009 
ART Success Rates Report focused on national summaries and 
clinic-specific data was published previously (1).
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Methods
National ART Surveillance System
CDC obtained ART data for 1995–2003 from the Society 
of Assisted Reproductive Technology (SART) through their 
proprietary Clinical Outcomes Reporting System (CORS) data 
base, or SART CORS. Since 2004, CDC has contracted with 
Westat, Inc., a statistical survey research organization, to obtain 
data from fertility clinics in the U.S through the National ART 
Surveillance System (NASS), a web-based data collection system 
developed by CDC (http://www.cdc.gov/art/NASS.htm).
Data collected include patient demographics, medical history, 
and infertility diagnoses; clinical information pertaining to the ART 
procedure type; and information regarding resultant pregnancies 
and births. The data file is organized with one record per ART 
procedure performed. Multiple procedures from individual patients 
are not linked. A few clinics (9%) do not report their data to CDC 
and are listed as nonreporting programs in the ART Success Rates 
Report as required by FCSRCA. Since nonreporting clinics tend to 
be smaller, NASS is estimated to contain information on >95% of all 
ART cycles in the United States. Because NASS collects information 
on deliveries, NASS data can be used to identify deliveries in which 
stillborn fetuses were delivered together with live-born infants. 
Because ART providers typically do not provide continued prenatal 
care after a pregnancy is established, birthweight and date of birth 
data are collected via active follow-up with ART patients (85%) or 
from their obstetric providers (15%).
ART Procedures
ART includes fertility treatments in which both eggs and sperm 
are handled in the laboratory (i.e., IVF and related procedures). 
ART does not include treatments in which only sperm are handled 
(i.e., intrauterine insemination) or procedures in which a woman 
takes drugs only to stimulate egg production without the intention 
of having eggs retrieved. Because an ART procedure consists of 
several steps over an interval of approximately 2 weeks, a procedure 
often is referred to as a cycle of treatment. An ART cycle generally 
begins with drug-induced ovarian stimulation. If eggs are produced, 
the cycle progresses to the egg-retrieval stage. After the eggs are 
retrieved, they are combined with sperm in the laboratory through 
IVF. If this is successful, the most viable embryos (i.e., those most 
likely to implant) are selected for transfer. If an embryo implants 
in the uterus, a clinical pregnancy is diagnosed by the presence of 
a gestational sac detectable by ultrasound. Most pregnancy losses 
occur by the first 12 weeks, with the risk of pregnancy loss increasing 
with the age of the mother (17). Beyond 12 weeks of gestation, the 
pregnancy usually progresses to a live-birth delivery, which is defined 
as the delivery of one or more live-born infants.
ART procedures are classified into four types based on the 
source of the egg (patient or donor) and the status of the 
embryos (freshly fertilized or thawed): fresh embryo from the 
patient’s eggs or fresh embryos from donor eggs (fresh embryo 
cycles), and thawed embryos from the patient’s eggs or thawed 
embryos from donor eggs (thawed embryo cycles). ART 
procedures involving fresh embryos include an egg-retrieval 
stage. ART procedures that use thawed embryos do not include 
egg retrieval because the eggs were fertilized during a previous 
procedure, and the resulting embryos were frozen until the 
current procedure. An ART procedure can be discontinued at 
any step for medical reasons or by patient choice. 
Variables and Definitions
ART data and outcomes from ART procedures are presented by 
the patient’s state or territory of residence at the time of treatment. If 
this information was missing, the state or territory of residence was 
assigned as the state or territory in which the procedure was performed. 
This report presents data on all cycles initiated; however, most 
outcomes are based on cycles in which embryos were obtained 
and transferred. The number of ART procedures performed per 
1 million women in the reproductive age group (15–44 years) 
was calculated. This ratio approximates the proportion of women 
of reproductive age who used ART in each state or territory and 
is a proxy measure of ART utilization. However, this is only an 
approximation because some women who used ART might fall 
outside the age range of 15–44 years, and some women might 
have had more than one procedure during the reporting period. 
Live-birth delivery was defined as birth of one or more live-born 
infants, with delivery of multiple infants counted as one live-birth 
delivery. A multiple birth was defined as a birth of two or more 
infants, at least one of whom was live-born. A delivery of a live-
born infant with one or more stillbirths was classified as a multiple 
birth. By contrast, CDC’s National Center for Health Statistics 
(NCHS), which bases its statistics on live birth records rather than 
delivery records, classifies the delivery of a single live-born infant 
with one or more stillbirths as a singleton birth (18).
Elective single-embryo transfer (eSET) is a procedure in 
which one embryo, selected from a larger number of available 
embryos, is placed in the uterus. This procedure does not 
include cycles in which only one embryo is available. The 
embryo selected for eSET might be from a previous IVF 
cycle (e.g., cryopreserved [frozen] embryos) or from the 
current fresh IVF cycle that yielded more than one embryo. 
The remaining embryos might be set aside for future use 
through cryopreservation. In this report, eSET was calculated 
only for fresh, nondonor cycles in which the total number of 
oocytes/embryos transferred was equal to one and the number 
of embryos cryopreserved was one or more.
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The average number of embryos transferred for three age 
groups (<35 years, 35–40 years, and >40 years) was calculated by 
dividing the total number of embryos transferred (for cycles that 
were not cancelled and in which a transfer was attempted) by the 
total number of embryo-transfer procedures initiated in that age 
group. The percentage of eSET was calculated by dividing the 
total number of transfer procedures, in which only one embryo 
was transferred and one or more embryos were cryopreserved, 
by this numerator plus the total number of transfer procedures 
in which more than one embryo were transferred.
Low birthweight was defined as <2,500 grams, moderate 
low birthweight was defined as 1,500–2,500 grams, and very 
low birthweight was defined as <1,500 grams. Gestational age 
was estimated as date of birth minus date of egg retrieval (and 
fertilization). For comparability with the general population, for 
whom gestational age is based on the date of the last menstrual 
period (LMP), gestational age was calculated for fresh cycles by 
subtracting the date of retrieval from the birth date and adding 
14 days. For frozen cycles, and for fresh cycles, if the date of 
retrieval was not available, gestational age was calculated by 
subtracting the date of transfer from the birth date and adding 
17 days (to account for an average of 3 days in embryo culture). 
Preterm delivery was defined as gestational age <37 weeks. 
Moderate preterm delivery was defined as gestational age 32–36 
weeks and very preterm delivery as gestational age <32 weeks (19).
The contribution of ART to an outcome was calculated by 
dividing the total number of ART outcomes by the total number 
of overall outcomes. The contribution of ART to all infants born 
was calculated by plurality (singleton, multiples, twins, and 
triplets or higher order births) and by adverse perinatal outcomes 
(low birthweight and prematurity). The contribution of ART to 
total infants born in the state or territory was used as a second 
measure of ART utilization. The number and percentage of 
infants (ART and all) born in the state or territory were calculated 
for singletons, multiples, twins, and triplets or higher order births 
and for different categories of birthweight and gestational age. 
Content of the Report
This report provides detailed information on rates of preterm 
birth and low birthweight for infants conceived with ART as 
well as for overall U.S. births. In addition, state-specific data on 
determinants of multiple gestations (e.g., the number of embryos 
transferred) and the prevalence of elective single-embryo transfers 
(eSET) are presented for women who underwent ART procedures.
This report provides data on the number and outcomes of all 
ART procedures initiated in the 50 states, the District of Columbia, 
Guam, the Federated Republic of Micronesia, the Commonwealth 
of Puerto Rico, and the U.S. Virgin Islands in 2009.† Live-birth 
delivery rates, the number of live-born infants, live singleton and 
multiple birth deliveries, and data regarding the number of ART 
procedures in relation to the number of women in the reproductive 
age group (15–44 years) are reported (20).§ Data also are presented 
on the number of embryo-transfer procedures performed, the 
average number of embryos transferred, and the percentage of eSET 
procedures performed among women who used fresh embryos from 
their own eggs, by age group, for each state and territory. 
For each state and territory, the proportion of singleton, 
multiple, twin, and triplet or higher order births resulting from 
ART are compared with their respective ratios in the overall births 
in that state in 2009. Overall births include all births in the state or 
territory during that year, both naturally conceived and resulting 
from ART and other infertility treatments. So that the proportion 
of ART births among overall U.S. births in 2009 could be assessed 
accurately, ART births were aggregated from 2 reporting years: 
1) infants conceived from ART procedures performed in 2008 
and born in 2009 (approximately 70% of the live-birth deliveries 
reported to the ART surveillance system for 2009) and 2) infants 
conceived from ART procedures performed in 2009 and born in 
2009 (approximately 30% of the live-birth deliveries reported to 
the ART surveillance system for 2009). Data on the total number 
of live-births and multiple births in each state and territory in 
2009 were obtained from U.S. natality files (18). Finally, the 
report presents number and percentage of select adverse perinatal 
outcomes (low birthweight, moderate low birthweight, very low 
birthweight, preterm delivery, moderate preterm delivery and very 
preterm delivery) among ART births and overall births, as well as 
the contribution of ART to these outcomes. 
Results
Overview of Fertility Clinics
Of 484 fertility clinics in the U.S. states and territories that 
performed ART procedures in 2009, a total of 441 (91%) 
provided data to CDC (Figure 1) with the majority located in 
the eastern United States, in or near major cities. The number 
of fertility clinics performing ART procedures varied by state. 
States with the largest number of fertility clinics reporting data 
for 2009 were California (61), New York (36), Texas (35), 
Illinois (28), Florida (28), and New Jersey (22). 
Number and Type of ART Procedures
The number, type, and outcome of ART procedures initiated for 
the 50 states and territories in 2009 are provided (Table 1). State 
residency data were missing for approximately 4% of procedures 
† Numbers <20 are not reported to preserve confidentiality but are included in totals. 
§ Data regarding population size are based on July 1, 2010, estimates from the 
U.S. Census Bureau (18).
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started and 3% of live-birth deliveries but are included in the 
total as discussed previously. Approximately, 16% of ART cycles 
were conducted among out of state residents. Non-U.S. residents 
accounted for approximately 2% of ART procedures, live-birth 
deliveries, and infants born.
Nationally, a total of 146,244 ART procedures were reported 
to CDC (Figure 1; Table 1). Of the 146,244 procedures started, 
124,391 (85%) progressed to embryo transfer (Table 1). Overall, 
45% (56,399/124,391) of ART procedures that progressed to 
the transfer stage resulted in a pregnancy, 37% (45,870/124,391) 
resulted in a live-birth delivery, 26% (32,205/124,391) resulted 
in a singleton live-birth delivery, and 11% (13,665/124,391) 
resulted in a multiple live-birth delivery (Figure 2). The 45,870 
live-birth deliveries from ART procedures performed in 2009 
resulted in 60,190 infants (32,205 singleton live-birth deliveries 
and 13,665 multiple live-birth deliveries) (Table 1).
California, the state with the most fertility clinics, also had the 
highest number of ART procedures performed among residents 
(18,405). The other states with the largest numbers of ART 
procedures performed among residents were New York (14,539), 
Illinois (10,192), Massachusetts (9,845), New Jersey (9,146) and 
Texas (8,244). Three of these states (California, Texas, and Illinois) 
also ranked high (first, second, and fourth) in overall births. Overall, 
these six states accounted for 48% of all ART procedures initiated 
in the United States. Correspondingly, the number of procedures 
that progressed to embryo transfers was the highest in these six 
states (California: 15,953; New York: 12,183; Illinois: 8,358; 
Massachusetts: 8,469; New Jersey: 7,720; and Texas: 7,267) and 
accounted for 48% of all embryo transfers in the United States. The 
number and percentages of infants born were the highest in these 
six states (California: 7,519 [12.5%]; New York: 4,725 [7.9%]; 






FIGURE 1. Locations of clinics providing assisted reproductive technology (ART) — United States, 2009*
* Number of ART clinics in the United States in 2009: 484; number of ART clinics that submitted data in 2009: 441; number of ART cycles reported in 2009: 146,244 
(does not include 12 cycles in which a new treatment procedure was being evaluated); number of live-birth deliveries resulting from ART cycles started in 2009: 
45,870; number of infants born as a result of ART cycles performed in 2009: 60,190.
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[6.2%]; Massachusetts: 3,401 [5.7%]) and 
accounted for 46% of all infants born from ART 
in the United States but only 34% of all births. 
Multiple live-birth deliveries were also highest 
among these states (California: 1,720 [12.6%]; 
Texas: 1,126 [8.2%]; New York: 967 [7.1%]; 
New Jersey: 861[6.3%]; Illinois: 856 [6.3%]; 
Massachusetts: 650 [4.8%]) and accounted for 
45% of all ART multiple live-birth deliveries 
(13,665).
The number of ART procedures per 
million women of reproductive age varied 
from 280 in Puerto Rico to 7,260 in 
Massachusetts, with an overall national 
average (mean) of 2,361 procedures per 1 
million women of reproductive age. Thirteen 
states had ratios higher than the national 
average, of which five had ratios exceeding 
twice the national average (Massachusetts 
(7,260), New York (6,848), the District of 
Columbia (6,146), New Jersey (5,345), and 
Connecticut (4,893)), and three had ratios 
exceeding one and half times the national 
average (Maryland (4,142), Illinois (3,851), 
and Delaware (3,558)) (Figure 3). 
Embryo Transfer and 
Patient’s Age
The number of embryo-transfer procedures 
performed, the average number of embryos 
transferred per procedure, and the percentage 
of elective single-embryo transfers (eSET) 
performed by age group for each state and 
territory, among women who used fresh 
embryos from their own eggs are provided 
(Table 2). In most states and territories, the 
highest number of embryo-transfer procedures performed was 
among women aged <35 years and lowest among women aged 
>40 years. Only nine states (California, Connecticut, Florida, 
Hawaii, Vermont, Maryland, Massachusetts, New York, and 
Virginia), the District of Columbia, and New York City had 
more embryo-transfer procedures among women aged 35–40 
years than among younger women. Nationally, the average 
number of embryos transferred varied from 2.1 among women 
aged <35 years (ranging from 1.8 to 2.4) to 2.5 among women 
aged 35–40 years (ranging from 2.0 to 3.0), and 3.0 among 
women aged >40 years (ranging from 1.7 to 3.5). Rates of elective 
single-embryo transfer (eSET) procedures varied by age group 
and by state and territory and were highest among women <35 
years and lowest among women aged >40 years. Nationally, 
rates of eSET ranged from 7.4% among women aged <35 years 
(ranging from 0 in several states to 41% in Delaware) to 2.8% 
among women aged 35–40 years (ranging from 0 in several states 
to 26% in Delaware) and 0.5% among women aged >40 years 
(ranging from 0 in most states to 4% in Arizona and Puerto 
Rico). Among women aged <35 years, the three states with the 
highest rates of eSET were Delaware (41%), Iowa (20%), and 
Massachusetts (17%). ESET rates were higher than the national 
average among all three age groups in Massachusetts and for both 
































FIGURE 2. Number of outcomes of assisted reproductive technology cycles, by stage 




























National average = 2,361
FIGURE 3. Number of procedures performed using assisted reproductive technology among 
women of reproductive age (15–44 years), per 1 million women — United States, 2009
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Singleton and Multiple Births
Among 4,180,540 infants born in the U.S in 2009, a total of 
60,001 (1.4%) were conceived with ART procedures initiated 
in 2008 and 2009 (Tables 3 and 4). California, Texas, and 
Florida ranked among the three highest states in overall births. 
Although singletons accounted for 96.5% of total infants born 
in 2009, singletons accounted for only 52.6% of all ART 
births. Only 0.1% (in Maine and Puerto Rico) to 2.6% (in 
Massachusetts) of singletons were conceived with ART.
Further, 0.2% (in Puerto Rico) to 4.3% (in Massachusetts) 
of infants were born with ART. The contribution of ART to 
overall births in the state was highest in Massachusetts where 
ART accounted for approximately 4.3% of all births, followed 
by New York (3.8%), Connecticut (3.7%), New Jersey (3.5%) 
and the District of Columbia (3.3%) (Table 3). 
The percentage of singletons among infants born from ART 
ranged from 39.2% in Wyoming to 65.3% in Delaware. The 
percentage of singletons among total births ranged from 95.2% 
in Connecticut to 99% in Guam (data not shown).
Nationwide, 47.3% (ranging from 34.7% in Delaware to 
60.8% in Wyoming) of ART infants were multiples compared 
with only 3.3% (ranging from 0.7% in New York to 4.8% 
in Connecticut) of all births (Table 4). ART multiple births 
contributed to 20.3 % (ranging from 4.1% in Maine to 
40.7% in New York) of total multiple-birth infants born. 
Approximately 43.7% (ranging from 31.6% in Delaware to 
54.9% in Wyoming) of all ART infants were twins compared 
with only 3.3% (ranging from 1.9% in Puerto Rico to 4.6% in 
Connecticut) of all births. ART twin birth infants accounted 
for 19% (ranging from 4.2% in Maine to 41.5% in New York) 
of all twins born in 2009. Finally, 3.6% of ART infants were 
triplets or higher order multiples (ranging from 0 in several 
states to 13.3% in Puerto Rico) compared with only 0.2% 
(with very little variation) of all births. ART triplets or higher 
order multiples accounted for 34.4% (ranging from 0 in several 
states to 61.5% in New Jersey and 100% in Montana) of all 
triplets or higher order births in 2009.
Adverse Perinatal Outcomes
Nationally, ART infants represented approximately 6% 
of all low birthweight, very low birthweight, and moderate 
low birthweight infants. The contribution of ART to low 
birthweight infants ranged from 1.3% in Mississippi to 14.6% in 
Massachusetts. The contribution of ART to very low birthweight 
infants ranged from 0.9% in Alaska to 15.2% in New Jersey. 
The contribution of ART to moderate low birthweight infants 
ranged from 1.3% in Mississippi to 15% in Massachusetts. In 
Connecticut, Massachusetts, and New Jersey, >10% of all low 
birthweight, moderate low birthweight, and very low birthweight 
infants born in these states were conceived with ART.
In all states and territories, rates of low birthweight, very low 
birthweight, and moderate low birthweight infants were higher 
among infants conceived with ART than in the general birth 
population (Table 5). Among ART infants, 32.3% were low 
birthweight infants (ranging from 19.7% in Alaska to 47.8% 
in Puerto Rico), compared with 8.1% in the general birth 
population (ranging from 5.8 % in South Dakota to 12.2% 
in Mississippi). Approximately 5.8% of ART infants were 
very low birthweight infants (ranging from 1.5% in Alaska to 
13.3% in South Dakota), compared with 1.4% in the general 
birth population (ranging from 1% in Alaska, Idaho, Maine, 
Missouri, Oregon, Utah, Washington) to 2.1% in Mississippi 
and District of Columbia). Approximately, 26.6% of ART 
infants were moderately low birthweight infants (ranging from 
14.7% in Vermont to 43.1% in Wyoming), compared with 
6.6% in the general birth population (ranging from 4.8% in 
South Dakota to 10.1% in Mississippi).
Nationally, infants conceived with ART contributed 
approximately 3.9%, 4.5% and 3.8% respectively to all 
preterm, very preterm, and moderate preterm births. The 
contribution of ART to preterm births ranged from 0.5% in 
Puerto Rico to 11.1% in Massachusetts. The contribution of 
ART to very preterm infants ranged from 0.5% in Puerto Rico 
to 12% in New York. The contribution of ART to moderate 
preterm birth infants ranged from 0.5% in Puerto Rico to 
11.1% in Massachusetts. In Massachusetts, New Jersey, and 
New York, >10% of all very preterm births in the state were 
conceived with ART. In addition, in Massachusetts and 
New York, births conceived with ART accounted for >10% 
of all preterm and moderate preterm births in these states.
Similar to low birthweight, rates of preterm, very preterm and 
moderate preterm births were higher among infants conceived 
with ART than in the general birth population (Table 6). 
Among ART infants, 33.4% were born preterm (ranging from 
21.3% in Vermont to 47.1% in Wyoming), compared with 
12.2% in the general birth population (ranging from 9.3% in 
Vermont to 18.0% in Mississippi). Approximately, 6.1% of all 
ART infants were very preterm (ranging from 1.5% in Alaska to 
14.7% in South Dakota), compared with 2.0% in the general 
birth population (ranging from 1.4% in Alaska, Oregon, Utah, 
and Washington to 3% in Mississippi). Approximately, 27.3% 
of all ART infants were moderate preterm birth infants (ranging 
from 12.0% in Vermont to 41.7% in Mississippi), compared 
with 10.2% in the general birth population (ranging from 
7.8% in Vermont to 15.4% in Puerto Rico). 
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Discussion
Overview
The use of ART has grown substantially in the United States 
since the beginning of ART surveillance. In 1996 (the first 
full year for which ART data were reported to CDC), 20,597 
infants were born from 64,036 ART cycles (21). Since then, 
the number of cycles reported to CDC has more than doubled 
while the number of infants born from ART procedures has 
nearly tripled. In 2009, a total of 146,244 cycles resulted in 
60,190 live-born infants, which is approximately 1.4% of 
total U.S. live-births. The impact of ART on multiple births 
and poor birth outcomes, however, is substantial because 
almost half of ART infants (47%) were born in multiple births 
(compared with only 3% of infants among the general birth 
population). On average, in all states and territories, more 
than one embryo was transferred among women aged <35 
years, thus resulting in high rates of multiple births. National 
rates of elective single-embryo–transfer procedures were low, 
especially among women aged >35 years. As a result, the rates 
of low birthweight and preterm births were substantially higher 
among ART infants (32% and 33% respectively) than in the 
general population (8% and 12% respectively). Overall, 19% 
of all twin births and 34% of triplet or higher order birth 
infants were conceived with ART. 
Variations by State
ART use varied widely by state, especially after controlling 
for the size of the population in reproductive age. Residents of 
California, New York, Illinois, New Jersey, Massachusetts, and 
Texas reported 46% of ART births but only 34% of all U.S. 
births. Rates of ART utilization were not correspondingly high 
in all six states. Only three of these six states (Massachusetts, 
New York, and New Jersey) were among the thirteen states with 
ART utilization above the national average (as measured by the 
number of ART procedures performed per 1 million women of 
reproductive age). By this measure, Massachusetts ranked first 
whereas California ranked twelfth nationally despite California 
having the highest overall number of ART procedures and the 
highest number of overall births. Further, the contribution of 
ART to total births was 4% in Massachusetts compared with 1% 
in California, which also suggests that ART utilization was higher 
in Massachusetts. Similarly, residents of the District of Columbia, 
New Jersey, Connecticut, Maryland, and Illinois, in addition 
to six other states, underwent more ART procedures relative to 
the national average as reflected by the high number of ART 
procedures performed per 1 million women of reproductive age. 
This divergence might be explained in part by variations in state 
health insurance coverage. Certain states (Massachusetts, Illinois, 
and New Jersey) had mandated comprehensive insurance coverage 
for ART procedures that must cover at least four cycles of IVF 
(22). This type of mandated insurance has been associated with 
greater use of ART (22–24). In addition, the higher rates of ART 
use observed in the Northeastern states (New York, Connecticut, 
and Delaware) also might be associated with the availability of 
insurance in neighboring states (Massachusetts and New Jersey). 
Patients might be willing to travel to other states if better treatment 
options are available. Clinic registries provide corroborating data, 
indicating that approximately 16% of U.S. ART cycles in 2009 
were performed on out-of-state residents.
State Insurance Mandates and Elective 
Single-Embryo Transfer Rates
Although many factors (e.g., a patient’s age and diagnostic 
factors) influence elective single-embryo transfer rates, 
increasingly, research shows that broad insurance mandates for 
IVF result not only in large increases in access to ART services 
but also in substantially fewer aggressive treatments, with fewer 
embryos transferred within a procedure (23,25). Typically, 
younger women are better candidates for eSET procedures 
because they might have more than one embryo available for 
transfer and better prognosis. Data indicate that eSET rates 
varied by age group and also by state. ESET procedures were 
more prevalent among women aged <35 years. ESET rates were 
higher than the national average among all three age groups in 
Massachusetts and for women aged <40 years in Illinois but 
not in New Jersey or Rhode Island, all of which had mandatory 
insurance for ART. Currently, 15 states have passed legislation 
mandating insurance coverage for infertility treatments; Illinois, 
Massachusetts, New Jersey, and Rhode Island also have universal 
mandates to cover IVF.§ Because ART procedures are expensive, 
attempts to reduce out-of-pocket costs might result in higher 
number of embryo transfers per attempt for uninsured patients. 
(23,25). In the United States, private insurance coverage of 
ART is rare. Even where mandated, coverage for infertility 
treatment often varies in scope, with some states requiring that 
all insurers cover ART whereas others require restricted coverage 
or merely offer plans that include ART coverage. The high use 
of eSET in Massachusetts and Illinois is consistent with the 
recommendations of the American Society for Reproductive 
Medicine (ASRM) on eSET (26). ESET rates also exceeded the 
national average in a number of states that do not have mandated 
insurance coverage for ART, especially among women aged <35 
years, suggesting greater compliance with ASRM guidelines.
§ States with restricted mandates are Arkansas, Hawaii, Louisiana, Maryland, 
Montana, Ohio, West Virginia, and New York. States with other insurance 
regulations on ART or other infertility treatments but not requiring coverage 
of ART are Connecticut, Texas, and California.
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ART Multiple Births
In the United States, on average, more than one embryo was 
transferred in ART procedures, even among younger women. 
Because most states do not have mandated insurance coverage, 
and the majority of insurance plans do not cover IVF treatments, 
to control costs, patients and providers might be willing to transfer 
multiple embryos to maximize the chance of live-birth delivery in a 
single procedure. Evidence also suggests that after years of failure to 
conceive, infertile couples might prefer multiple births, especially 
twins, in their desire to achieve parenthood, and might not estimate 
the risks of such pregnancies accurately. Infertile women might be 
more receptive to the idea of a multiple birth than fertile women 
(27,28). Therefore, understanding the viewpoint of couples 
undergoing infertility treatments about multiple births is an 
important consideration. In 2009, almost half of all ART infants 
were born in multiple births. During 1980–2009, the twin birth 
rate in the United States, which comprises the majority of multiple 
births, increased by 76%, from 18.9 to 33.3 per 1,000 births 
(29). In 2009, one in every 30 babies born in the United States 
was a twin, compared with one in every 53 babies in 1980. The 
increased use of infertility treatments, both ART and non-ART 
fertility treatments (ovulation stimulation medications without 
ART), likely are associated with this sharp increase (30). Because 
of the risks associated with multiple-gestation pregnancies, the best 
outcomes of IVF treatment are a healthy singleton pregnancy and 
a singleton birth (31). Singleton live-birth deliveries have much 
lower risks than multiple-infant births for adverse birth outcomes 
such as prematurity, low birthweight, disability, and death.
The number of embryos transferred is a crucial determinant of 
multiple-birth deliveries. The data provided in this report indicate 
that a few states with universal mandated insurance coverage 
had lower multiple ART births (Illinois and Massachusetts), 
as well as lower rates of low birthweight and preterm births 
(Massachusetts), compared with those with more restricted 
coverage (e.g., California). However, Illinois, Massachusetts, and 
California were all among the states with the highest percentage 
of multiple live-birth deliveries resulting from ART. Massachusetts 
was among the three states in which >10% of all low, moderate, 
and very low birthweight, as well as preterm, very preterm, and 
moderate preterm infants were conceived with ART. Although 
more research is needed in this area, broader insurance coverage for 
ART procedures has been associated with lower rates of multiple 
births (24,25). The economic costs of multiple births are also 
much higher compared with singleton births. The mean medical 
cost of delivering a singleton baby was estimated to be $9,329, 
whereas a set of twins costs $20,318, and triplets have a delivery 
expense of $153,335 (32). Transferring two embryos is associated 
with a more than threefold increase in the birth rate and a more 
than 16-fold increase in the twin birth rate (33). In 2009, the 
transfer of more than two embryos was still a common practice 
in most states and territories, even among younger patients. As a 
result of these findings, clinicians and state policy makers should 
continue to support fewer numbers of embryos transferred 
and, when possible, promote the transfer of single embryos as 
recommended by the SART and ASRM guidelines on the number 
of embryos transferred based on a patient’s age and prognosis (34). 
The guidelines on the number of embryos transferred were revised 
in 2004 (35), 2006 (36), 2008 (37), and 2009 (38). At the 2011 
annual meeting, the ASRM Practice Committee noted that the 
most direct way to limit the risk of multiple gestations from ART 
is to transfer single embryos (31). 
ART Low Birthweight Infants and 
Preterm Births
The rates of low birthweight and very low birthweight infants 
were disproportionately higher among ART infants than in 
the general birth population. Three states (Massachusetts, 
New Jersey, and New York) with high number of ART 
cycles and births also had high ART contributions (>10%) 
to very preterm births. The contribution of ART to preterm 
and moderate preterm births were also very high (>10%) in 
Massachusetts and New York. The contribution of ART to 
preterm births in the United States, most of which are also low 
birthweight, is a key concern. Since 1981, the rate of preterm 
births in the United States has increased >30% (39). Fertility 
treatments, both ART and controlled ovarian stimulations, 
contribute substantially to preterm births among both multiple 
and singleton pregnancies (39). Preterm births are a leading 
cause of infant mortality and morbidity, and preterm infants 
are at increased risk for death and have more health and 
developmental problems than full-term infants (39,42). The 
health risks associated with preterm births have contributed to 
increasing health-care costs. In 2005, the estimated economic 
burden associated with preterm births in the United States was 
$26 billion ($51,600 per infant born preterm) (39). 
Limitations
The findings in this report are subject to at least seven 
limitations. First, ART surveillance data were reported for each 
ART procedure performed rather than for each patient who 
used ART. Linking procedures among patients who underwent 
more than one ART procedure in a given year is not possible 
with these data. Second, because patients who underwent more 
than one procedure in a given year were most likely to include 
those in which a pregnancy was not achieved during that year 
but were likely to do so with repeated treatments, the success 
rates reported might likely underestimate the actual per-patient 
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success rate. Third, the contribution of ART to multiples also 
might be slightly overestimated because stillborn infants were 
included in our definition of multiple births. Fourth, data are 
reported only for couples who sought ART services and do not 
represent all couples with infertility who were potential users 
of ART during that time. Fifth, a small percentage of fertility 
clinics that performed ART in 2009 did not report their data 
to CDC and might have had results different from clinics that 
reported their data. Sixth, for four states (Connecticut, Georgia, 
Massachusetts, and Pennsylvania) a substantial percentage 
(Connecticut: 5.6%, Pennsylvania: 9.8%, Georgia: 19.8%, and 
Massachusetts:32.3%) of residency information was missing 
for procedures started in 2009. Finally, overall, residency data 
were missing for approximately 4% of procedures started and 
3% of all live-birth deliveries resulting from ART procedures 
started in 2009. Despite these limitations, the findings from 
this report provide useful information to ART providers, state 
health-care policy makers, and researchers. 
Conclusion
ART-conceived infants now represent a substantial 
proportion of infants born in the United States, ranging from 
0.2% to 4% of all infants born in U.S. states and territories. 
The majority of these infants were born from multiple-
gestation pregnancies and resulted in multiple births. This 
report is the first to document the contribution of ART to 
multiple births, low birthweight, and preterm births by each 
state/territory and allows State Health Departments to monitor 
the extent of ART-related adverse perinatal outcomes in their 
individual state and territories.
Comprehensive insurance coverage of ART might increase 
access to fertility treatments. It also might increase the use 
of elective single-embryo transfers, where feasible. Further 
research is needed to ascertain the influence of state insurance 
mandates on ART use and outcomes, as well as the economic 
costs of multiple births (22–25), including out-of-pocket costs 
to patients. Addressing the risk of multiple births also requires 
understanding the perspectives of couples undergoing infertility 
treatments who might not fully consider the risks of multiple 
births, especially twins. Clinicians and patients should continue 
to strengthen and support ongoing efforts to limit the number 
of embryos transferred and encourage wider implementation 
of elective single-embryo transfers, when feasible, as one 
mechanism of promoting singleton infant births among ART-
conceived pregnancies.
CDC is working to extend the utility of NASS by linking to 
data collected by states (birth certificate, infant deaths, hospital 
discharge, birth defect registries, and cancer registries) to 
conduct state-based surveillance of ART, infertility and related 
issues. This initiative, the States Monitoring ART (SMART) 
Collaborative,¶ has been determined to be feasible and useful, 
especially for monitoring long-term outcomes of ART (43). 
To date, data from NASS have been linked with vital records 
files from three states (Florida, Massachusetts, and Michigan). 
The overarching purpose of the SMART Collaborative is to 
strengthen the capacity of states to evaluate maternal and 
perinatal outcomes and programs through state-based public 
health surveillance systems.
Further efforts also are needed to monitor the use of non-
ART infertility treatments and their role in the rising number 
of multiple births (39). Despite its substantial impact on 
adverse birth outcomes, ART only partially explains the overall 
prevalence of these adverse outcomes in the United States. 
Preterm births resulting from controlled ovarian stimulation 
(superovulation-intrauterine insemination and conventional 
ovulation induction) might contribute as much as ART to 
multiple gestations (39). More research is needed to identify 
the causes and consequences of preterm births that occur 
because of infertility treatments and to institute guidelines to 
reduce the number of multiple gestations (39). The risk for 
multiple gestations associated with these treatments is less well 
documented, as clinics are not mandated to report data on the 
use of non-ART infertility treatments. Recent studies have 
demonstrated that singleton infants conceived with ovulation 
stimulation are more likely to be small for gestational age (44). 
CDC is monitoring the prevalence of non-ART infertility 
treatment use among women who had live births and their 
resultant outcomes in several states through the Pregnancy Risk 
Assessment Monitoring System (PRAMS), a population-based 
surveillance system of maternal and infant health indicators 
funded in part by CDC and administered by state health 
departments (information available at http://www.cdc.gov/
PRAMS) (45). The most recent ART Surveillance Summary 
was published by CDC in 2009 (46). CDC will continue 
to provide updates of ART use in the United States as data 
become available.
References
 1. CDC. American Society for Reproductive Medicine, Society for Assisted 
Reproductive Technology. 2009 assisted reproductive technology success rates. 
Atlanta, GA: US Department of Health and Human Services, CDC; 2011. 
 2. CDC. American Society for Reproductive Medicine, Society for 
Assisted Reproductive Technology, RESOLVE. 1995 assisted 
reproductive technology success rates. Atlanta, GA: US Department 
of Health and Human Services, CDC; 1997. 
 3. Schieve LA, Peterson HB, Meikle SF, et al. Live-birth rates and multiple-
birth risk using in vitro fertilization. JAMA 1999;282:1832–8. 
¶ SMART is a collaboration between CDC and state health departments in 
Massachusetts, Michigan, and Florida (information available at http://www.
cdc.gov/art/smart.htm).  
Surveillance Summaries
MMWR / November 2, 2012 / Vol. 61 / No. 7 11
 4. Schieve LA, Meikle SF, Peterson HB, Jeng G, Burnett NM, Wilcox LS. 
Does assisted hatching pose a risk for monozygotic twinning in pregnancies 
conceived through in vitro fertilization? Fertil Steril 2000;74:288–94. 
 5. Reynolds MA, Schieve LA, Martin JA, Jeng G, Macaluso M. Trends in 
multiple births conceived using assisted reproductive technology, United 
States, 1997–2000. Pediatrics 2002;111:1159–62. 
 6. Reynolds MA, Schieve LA, Jeng G, Peterson HB, Wilcox LS. Risk of 
multiple birth associated with in vitro fertilization using donor eggs. 
Am J Epidemiol 2001;154:1043–50. 
 7. Vahratian A, Schieve LA, Reynolds MA, Jeng G. Live-birth rates and multiple-
birth risk of assisted reproductive technology pregnancies conceived using 
thawed embryos, USA, 1999–2000. Hum Reprod 2002;18:1442–8. 
 8. Wright V, Schieve LA, Vahratian A, Reynolds MA. Monozygotic 
twinning associated with day 5 embryo transfer in pregnancies conceived 
after IVF. Hum Reprod 2004;19:1831–6. 
 9. Kissin DM, Schieve LA, Reynolds MA. Multiple-birth risk associated with IVF 
and extended embryo culture: USA, 2001. Hum Reprod 2005;20:2215–23. 
 10. Reynolds MA, Schieve LA. Trends in embryo transfer practices and 
multiple gestation for IVF procedures in the USA, 1996–2002. Hum 
Reprod 2006;21:694–700. 
 11. European Society of Human Reproduction and Embryology (ESHRE) 
Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod 
2000;15:1856–64. 
 12. Mackay AP, Berg CJ, King JC, Duran C, Chang J. Pregnancy-related 
mortality among women with multifetal pregnancies. Obstet Gynecol 
2006;107:563–8. 
 13. Bukulmez O. Does assisted reproductive technology cause birth defects? Curr 
Opin Obs Gyn [1040-872X] 2009;21:260–4.
 14. Reefhuis J, Correa A, Hobbs CA, Rasmussen SA; National Birth Defects 
Prevention Study. Assisted reproductive technology and major structural 
birth defects in the United States. Hum Reprod 2009;24:360–6.
 15. Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low 
and very low birthweight in infants conceived with use of assisted 
reproductive technology. N Engl J Med 2002;346:731–7.
 16. Schieve LA, Ferre C, Peterson HB, Macaluso M, Reynolds MA, Wright 
VC. Perinatal outcomes among singleton infants conceived through 
assisted reproductive technology in the United States. Obstet Gynecol 
2004;103:1144–53.
 17. Farr SL, Schieve LA, Jamieson DJ. Pregnancy loss among pregnancies 
conceived through assisted reproductive technology, United States, 
1999–2002. Am J Epidemiol 2007;165:1380–8.
 18. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2009. 
National Vital Stat Rep 2009;57:1–104.
 19. Kramer MR, Hogue CR. What causes racial disparities in very preterm 
birth? A biosocial perspective. Epidemiol Rev 2009;31:84–98.
 20. US Census Bureau. Annual estimates of the population for the United 
States and states, and for Puerto Rico: April 1, 2000 to July 1, 2010 
(NST-EST2010-01). Available at http://factfinder.census.gov.
 21. CDC. American Society for Reproductive Medicine, Society for Assisted 
Reproductive Technology, RESOLVE. 1996 assisted reproductive 
technology success rates. Atlanta, GA: US Department of Health and 
Human Services, CDC; 1998.
 22. Henne MB, Bundorf MK. Insurance mandates and trends in infertility 
treatments. Fertil Steril 2008;89:66–73.
 23. Hamilton BH, McManus, B. The effects of insurance mandates on choices 
and outcomes in infertility treatment markets. Health Economics. doi: 
10.1002/hec.1776. 2011.
 24. Bitler MP, Schmidt L. Utilization of infertility treatments: the effects of 
insurance mandates. Demography 2012;49:125–49.
 25. Jain T, Harlow BL, Hornstein MD. Insurance coverage and outcomes 
of in vitro fertilization. N Engl J Med 2002;347:661–6.
 26. The Practice Committee of the Society for Assisted Reproductive 
Technology, the American Society for Reproductive Medicine. Elective 
single-embryo transfer. Fertil Steril 2012;97: 835–42.
 27. Grobman W, Milad M, Stout J, Klock S. Patient perceptions of multiple 
gestations: an assessment of knowledge and risk aversion. Am J Obstet 
Gynecol 2001;185:920–4.
 28. Blennborn M, Nilsson, S, Hillervik, C, Hellberg, D. The couple’s 
decision-making in IVF: one or two embryos at transfer? Hum Reprod 
2005;20:1292–7.
 29. Martin JA, Hamilton BE, Osterman MJK. Three decades of twin births 
in the United States, 1980–2009. NCHS data brief, no 80. Hyattsville, 
MD: US Department of Health and Human Services, CDC, National 
Center for Health Statistics; 2012.
 30. Schieve LA, Devine O, Boyle CA, Petrini JR, Warner L. Estimation of 
the contribution of non-assisted reproductive technology ovulation 
stimulation fertility treatments to US singleton and multiple births. Am 
J Epidemiol 2009;170:1396–407.
 31. The Practice Committee of the American Society for Reproductive 
Medicine. Multiple gestation associated with infertility therapy: an 
ASRM Practice Committee Opinion. Fertil Steril 2012;97:825–34. 
 32. Hidlebaugh DA, Thompson IE, Berger MJ. Cost of assisted reproductive 
technologies for a health maintenance organization. J Reprod 
Med;1997;42: 570–4.
 33. Henne, MB and Bundorf MK. The effects of competition on assisted 
reproductive technology outcomes. Fertil Steril 2010;93:1820–30. 
 34. American Society for Reproductive Medicine. Guidelines on number 
of embryos transferred. Birmingham, AL: American Society for Assisted 
Reproductive Medicine; 1999.
 35. The Practice Committee of the Society for Assisted Reproductive Technology, 
the American Society for Reproductive Medicine. Guidelines on the number 
of embryos transferred. Fertil Steril 2004;82(Suppl 1):1–2.
 36. The Practice Committee of the Society for Assisted Reproductive Technology, 
the American Society for Reproductive Medicine. Guidelines on the number 
of embryos transferred. Fertil Steril 2006;86(Suppl 5):S51–2.
 37. The Practice Committee of the Society for Assisted Reproductive Technology, 
the American Society for Reproductive Medicine. Guidelines on the number 
of embryos transferred. Fertil Steril 2008;90(Suppl 3):S163–4.
 38. The Practice Committee of the Society for Assisted Reproductive Technology, 
the American Society for Reproductive Medicine. Guidelines on the number 
of embryos transferred. Fertil Steril 2009;92:1518–9.
 39. Behrman RE, Behrman RE, Stith Butler A, eds. Preterm birth: causes, 
consequences, and prevention. Washington, DC: National Academies 
Press; 2006.
 40. Callaghan WM, MacDorman MF, Rasmussen SA, Qin C, Lackritz EM. 
The contribution of preterm birth to infant mortality rates in the United 
States. Pediatrics 2006;118:1566–73.
 41. Tanner K, Sabrine N, Wren C. Cardiovascular malformations among 
preterm infants. Pediatrics 2005;116:e833–8.
 42. Rasmussen SA, Moore CA, Pauloi LJ, Rhodenhiser EP. Risk for birth 
defects among premature infants: a population-based study. J Pediatr 
2001;138:668–73.
 43. Kissin DK, Jamieson DJ, Barfield W. Assisted reproductive technology 
program reporting. JAMA 2011;306: 2564; author reply:2564–5.
 44. D’Angelo DV, Whitehead N, Helms K, Barfield WD, Ahuwalia IB. 
Birth outcomes of intended pregnancies among women who used assisted 
reproductive technology, ovulation stimulation, or no treatment. Fertil 
Steril 2011;96:314–20.
 45. Barradas DT, Barfield WD, Wright V, D’Angelo D, Manning SE, Schieve 
LA. Assessment of assisted reproductive technology use questions: 
Pregnancy Risk Assessment Monitoring System Survey, 2004. Public 
Health Rep 2012;127:516–23.
 46. Sunderam S, Chang J, Flowers L, et al. Assisted reproductive technology 
surveillance—United States, 2006. MMWR 2009;58(No. SS-5).
Surveillance Summaries
12 MMWR / November 2, 2012 / Vol. 61 / No. 7
TABLE 1. Number and outcomes of assisted reproductive technology (ART) procedures, by female patient’s state/territory of residence* at time 



























 Ratio (per million)†
Alabama 879 747 367 305 214 91 402 925
Alaska 188 163 71 56 42 § 71 1,300
Arizona 2,105 1,893 875 710 485 225 954 1,622
Arkansas 438 388 189 163 129 34 197 771
California 18,405 15,953 7,155 5,710 3,990 1,720 7,519 2,392
Colorado 1,756 1,549 869 727 476 251 994 1,709
Connecticut¶ 3,368 2,832 1,319 1,057 782 275 1,341 4,893
Delaware 629 476 202 154 127 27 182 3,558
District of Columbia** 927 761 355 279 206 73 353 6,146
Federated States of Micronesia § § § § § § § §
Florida 6,097 5,113 2,288 1,894 1,309 585 2,507 1,750
Georgia¶ 3,095 2,692 1,287 1,052 695 357 1,424 1,482
Guam § § § § § § § §
Hawaii 708 568 220 166 108 58 225 2,841
Idaho 470 443 190 162 102 60 224 1,534
Illinois 10,192 8,358 3,587 2,918 2,062 856 3,817 3851
Indiana 1,666 1,356 604 513 342 171 702 1,300
Iowa 1,107 919 534 447 337 110 559 1,916
Kansas 713 600 315 263 183 80 346 1,287
Kentucky 1,026 888 381 319 216 103 431 1,188
Louisiana 872 735 363 309 211 98 418 937
Maine 128 112 45 36 23 § 49 521
Maryland 4,871 4,110 1,842 1,488 1,116 372 1,876 4,142
Massachusetts¶ 9,845 8,469 3,403 2,733 2,083 650 3,401 7,260
Michigan 3,197 2,754 1,323 1,093 736 357 1,469 1,629
Minnesota 2,102 1,847 920 783 530 253 1,042 2,009
Mississippi 445 376 148 126 90 36 163 735
Missouri 1,432 1,179 564 469 328 141 615 1,202
Montana 184 164 87 76 54 22 98 1,009
Nebraska 550 410 194 161 109 52 219 1,559
Nevada 945 820 421 333 229 104 441 1,789
New Hampshire 773 655 276 223 164 59 282 3,000
New Jersey 9,146 7,720 3,593 2,814 1,953 861 3,710 5,345
New Mexico 385 340 184 152 104 48 201 974
See table footnotes on page 13.
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TABLE 1. (Continued) Number and outcomes of assisted reproductive technology (ART) procedures, by female patient’s state/territory of 



























aged 15–44 yrs 
 Ratio (per million)†
New York†† 14,539 12,183 4,699 3,701 2,734 967 4,725 6,848
New York City 4,737 3,833 1,605 1,243 932 311 1,562 2,494
North Carolina 3,002 2,522 1,260 1,075 712 363 1,462 1,570
North Dakota 207 175 80 67 46 21 90 1,628
Ohio 3,600 3,071 1,342 1,114 790 324 1,458 1,585
Oklahoma 647 575 305 269 178 91 362 887
Oregon 1,048 945 503 440 283 157 601 1,388
Pennsylvania¶ 5,535 4,542 1,995 1,625 1,149 476 2,131 2,271
Puerto Rico 235 210 95 65 48 § 84 280
Rhode Island 722 621 225 180 132 48 228 3,383
South Carolina 1,022 883 436 375 255 120 500 1,118
South Dakota 222 199 67 63 48 § 78 1,446
Tennessee 1,087 926 441 376 268 108 488 856
Texas 8,244 7,267 3,804 3,169 2,043 1,126 4,359 1,591
Utah 999 866 436 382 244 138 527 1,640
Vermont 224 181 83 68 45 23 91 1,864
Virgin Islands § § § § § § § §
Virginia 4,930 4,190 1,896 1,515 1,098 417 1,945 3,021
Washington 2,562 2,230 1,203 997 680 317 1,327 1,905
West Virginia 259 229 112 100 74 26 129 752
Wisconsin 1,293 1,144 491 407 280 127 539 1,163
Wyoming 80 74 37 34 22 § 46 761
Nonresident 2,374 2,110 1,095 896 593 303 1,206 §§
Total 146,244 124,391 56,399 45,870 32,205 13,665 60,190 2,361
 * In cases of missing residency data, the patient’s state of residence was assigned as the state in which the ART procedure was performed.
 † Source of population size: July 1, 2010, state population estimates. Population Division, U.S. Census Bureau, NST-EST 2010-01.
 § Data not provided to preserve confidentiality but included in totals.  
 ¶ A substantial percentage (6%–32%) of residency information was missing for procedures started in these four states. Overall, residency information was missing 
for 5,614 (4%) procedures started and 1,552 (3%) of live-birth deliveries. 
 ** Of all ART procedures, 0.5% were reported from military medical centers located in California, the District of Columbia, Hawaii, and Texas. States and territories for which 
≥1% of ART procedures among residents were performed in a military medical center were the District of Columbia, Hawaii, Maryland, Montana, New Mexico, South Dakota, 
Texas, Virginia, Washington, and Wyoming. In the District of Columbia, 13 % of ART procedures among residents were performed in a military medical center.
 †† Outcomes for New York do not include New York City, but denominator used to derive ratio of ART procedures started by population and women (aged 15–44 
years) includes New York City.
 §§ Non-U.S. residents excluded from ratio because the appropriate denominators were unknown.
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TABLE 2. Number of embryo transfer procedures among patients who used fresh embryos from their own eggs, by female patient’s age group 



























Alabama 346 2.0 (6.4) 171 2.5 (0.6) § 3.3 §
Alaska 49 2.2 (4.5) 41 2.5 (5.1) 22 3.3 §
Arizona 493 2.1 (5.7) 459 2.5 (2.2) 91 2.8 (3.8)
Arkansas 166 1.9 (14.9) 79 2.4 § § 3.0 §
California 3,397 2.2 (8.0) 4,822 2.7 (2.6) 2,009 3.2 (0.5)
Colorado 394 2.1 (8.2) 391 2.5 (1.4) 85 3.0 (1.3)
Connecticut¶ 814 2.0 (10.5) 965 2.4 (3.9) 317 3.1 §
Delaware 153 1.9 (40.6) 111 2.0 (25.5) 45 2.4 §
District Of Columbia 157 2.0 (9.0) 293 2.2 (6.3) 147 2.8 §
Federated States of 
Micronesia
§ § § § § § § § §
Florida 1,584 2.1 (5.9) 1,606 2.4 (1.0) 384 2.8 §
Georgia¶ 776 2.1 (7.2) 754 2.6 (2.7) 155 3.3 §
Guam § § § § § § § § §
Hawaii 117 2.3 § 206 3.0 (1.0) 89 3.4 §
Idaho 162 2.4 § 79 2.9 (3.9) § 3.4 §
Illinois 2,659 2.1 (8.7) 2,389 2.4 (3.7) 675 2.7 (0.2)
Indiana 542 2.2 (2.7) 309 2.4 (0.4) 44 2.8 §
Iowa 374 1.8 (20.0) 177 2.1 (11.5) 35 2.6 §
Kansas 239 2.0 (7.4) 116 2.1 (1.9) § 2.8 §
Kentucky 369 2.2 (2.3) 199 2.8 § 31 3.0 §
Louisiana 297 2.2 (2.1) 188 2.5 (0.6) 42 2.8 (3.2)
Maine 43 1.9 (2.6) 36 2.4 § § 1.7 §
Maryland 1,267 1.9 (13.6) 1,321 2.2 (4.5) 415 2.8 (0.6)
Massachusetts¶ 2,658 1.8 (17.4) 3,053 2.3 (4.5) 912 3.3 (0.6)
Michigan 946 2.2 (5.6) 649 2.5 (2.5) 134 2.8 §
Minnesota 701 1.9 (6.3) 499 2.2 (2.5) 82 2.7 §
Mississippi 166 2.1 § 82 2.4 § § 1.8 §
Missouri 468 2.1 (1.4) 263 2.5 (2.5) 45 3.5 §
Montana 56 2.1 (5.6) 34 2.4 (3.0) § 2.5 §
Nebraska 159 2.1 (4.0) 97 2.6 (1.1) § 3.1 §
Nevada 201 2.1 (8.1) 180 2.3 (3.3) 49 2.5 (2.6)
New Hampshire 243 1.8 (13.0) 216 2.2 (3.7) 55 3.1 §
New Jersey 2,336 2.1 (3.7) 2,304 2.5 (1.4) 872 2.9 (1.0)
See table footnotes on page 15.
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TABLE 2. (Continued) Number of embryo transfer procedures among patients who used fresh embryos from their own eggs, by female patient’s 



























New Mexico 101 2.1 (4.3) 89 2.6 § § 3.1 §
New York** 3,160 2.2 (6.5) 3,542 2.6 (2.5) 1,744 2.9 (0.6)
New York City 697 2.1 (5.5) 1,198 2.6 (3.9) 809 3.1 (1.1)
North Carolina 851 2.1 (4.0) 670 2.5 (1.7) 130 3.1 §
North Dakota 52 2.0 (2.1) 45 2.2 (4.8) § 2.9 §
Ohio 1,152 2.2 (1.5) 777 2.5 (1.4) 143 3.2 §
Oklahoma 270 2.1 (0.8) 134 2.2 (2.5) 26 2.7 §
Oregon 244 2.2 (1.3) 221 2.4 (1.0) 66 3.1 §
Pennsylvania¶ 1,486 2.1 (6.3) 1,232 2.5 (2.4) 284 2.8 (0.9)
Puerto Rico 86 2.3 § 73 2.4 (1.5) 30 2.3 (3.8)
Rhode Island 214 2.0 (5.2) 207 2.4 (0.5) 63 3.4 §
South Carolina 304 2.0 (4.9) 228 2.4 (1.0) 31 2.9 §
South Dakota 80 2.0 (13.3) 52 2.5 (2.1) § 2.0 §
Tennessee 312 2.0 (6.8) 187 2.4 (3.4) 41 2.7 §
Texas 2,529 2.1 (4.5) 1,986 2.4 (1.9) 478 3.0 (0.7)
Utah 400 2.1 (6.7) 138 2.3 (0.8) 31 3.1 §
Vermont 58 1.9 (10.2) 61 2.3 (6.9) § 1.9 §
Virgin Islands § § § § § § § § §
Virginia 1,145 1.9 (9.8) 1,319 2.3 (3.5) 383 2.8 §
Washington 645 2.0 (12.8) 612 2.4 (5.0) 140 3.0 §
West Virginia 84 2.0 (11.5) 56 2.5 (4.1) § 2.8 §
Wisconsin 408 2.1 (5.7) 270 2.3 (2.5) 47 3.0 §
Wyoming 36 2.0 § § 2.3 § § 2.7 §
Nonresident 315 2.2 †† †† 2.6 (0.5) †† 2.9 (1.0)
Total 36,966 2.1 (7.4)§§ 35,620 2.5 (2.8)§§ 11,445 3.0 (0.5)§§
Abbreviation: eSET= elective Single Embryo Transfer.
 * In cases of missing residency data, the patient’s state of residence was assigned as the state in which the ART procedure was performed.
 † Percentages for eSET include nonresidents.
 § Data not provided to preserve confidentiality but included in totals.
 ¶ A substantial percentage (6%–32%) of residency information was missing for procedures started in these four states.
 ** Outcomes for New York do not include New York City.
 †† Non-U.S. residents excluded because the appropriate denominators were unknown.
 §§ Excludes cancelled cycles and embryo transfers not attempted. 
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TABLE 3. Number, percentage, and proportion of infants born with the use of assisted reproductive technology (ART), by female patient’s 









% of infants born 
in state who are 
ART infants
No. and % of ART infants 
born in the state who are 
singletons§
Singletons among all infants 
born in the state†




in the stateNo. (%) No. (%)
Alabama 62,475 403 0.6 225 (55.8) 60,315 (96.5) 0.4
Alaska 11,324 66 0.6 32 (48.5) 10,965 (96.8) 0.3
Arizona 92,798 970 1.0 487 (50.2) 90,205 (97.2) 0.5
Arkansas 39,808 181 0.5 113 (62.4) 38,592 (96.9) 0.3
California 527,020 7,546 1.4 3,973 (52.7) 510,219 (96.8) 0.8
Colorado 68,628 986 1.4 467 (47.4) 66,284 (96.6) 0.7
Connecticut¶ 38,896 1,421 3.7 830 (58.4) 37,043 (95.2) 2.1
Delaware 11,559 190 1.6 124 (65.3) 11,165 (96.6) 1.1
District of Columbia 9,040 297 3.3 191 (64.3) 8,696 (96.2) 2.1
Federated States of Micronesia ** ** ** ** ** ** ** **
Florida 221,394 2,692 1.2 1,381 (51.3) 214,213 (96.8) 0.6
Georgia¶ 141,377 1,483 1.0 752 (50.7) 136,409 (96.5) 0.5
Guam 3,415 ** ** ** ** 3,366 (98.6) **
Hawaii 18,887 292 1.5 146 (50.0) 18,271 (96.7) 0.8
Idaho 23,737 217 0.9 95 (43.8) 23,041 (97.1) 0.4
Illinois 171,163 3,728 2.2 2,029 (54.4) 164,595 (96.2) 1.2
Indiana 86,673 680 0.8 341 (50.1) 83,774 (96.7) 0.4
Iowa 39,701 506 1.3 289 (57.1) 38,279 (96.4) 0.7
Kansas 41,396 383 0.9 185 (48.3) 40,072 (96.8) 0.4
Kentucky 57,551 473 0.8 257 (54.3) 55,664 (96.7) 0.4
Louisiana 64,973 396 0.6 183 (46.2) 62,869 (96.8) 0.3
Maine 13,470 36 0.3 ** (50.0) 13,032 (96.7) 0.1
Maryland 75,059 1,855 2.5 1,090 (58.8) 72,136 (96.1) 1.5
Massachusetts¶ 75,016 3,255 4.3 1,915 (58.8) 71,467 (95.3) 2.6
Michigan 117,294 1,574 1.3 786 (49.9) 112,965 (96.3) 0.7
Minnesota 70,646 1,039 1.5 531 (51.1) 68,036 (96.3) 0.8
Mississippi 42,901 175 0.4 84 (48.0) 41,331 (96.3) 0.2
Missouri 78,905 698 0.9 341 (48.9) 76,200 (96.6) 0.4
Montana 12,257 92 0.8 49 (53.3) 11,888 (97.0) 0.4
Nebraska 26,936 257 1.0 142 (55.3) 25,932 (96.3) 0.5
Nevada 37,612 519 1.4 248 (47.8) 36,536 (97.1) 0.7
See table footnotes on page 17.
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TABLE 3. (Continued) Number, percentage, and proportion of infants born with the use of assisted reproductive technology (ART),* by female 









% of infants born 
in state who are 
ART infants
No. and % of ART infants 
born in the state who are 
singletons§
Singletons among all infants 
born in the state†




in the stateNo. (%) No. (%)
New Hampshire 13,377 280 2.1 144 (51.4) 12,807 (95.7) 1.1
New Jersey 110,331 3,821 3.5 1,970 (51.6) 105,215 (95.4) 1.8
New Mexico 29,000 208 0.7 107 (51.4) 28,328 (97.7) 0.4
New York 125,784 4,837 3.8 2,611 (54.0) 120,309 (95.6) 2.1
New York City 122,326 1,603 1.3 920 (57.4) 117,754 (96.3) 0.8
North Carolina 126,845 1,436 1.1 686 (47.8) 122,360 (96.5) 0.5
North Dakota 9,001 101 1.1 47 (46.5) 8,709 (96.8) 0.5
Ohio 144,841 1,503 1.0 777 (51.7) 139,734 (96.5) 0.5
Oklahoma 54,553 323 0.6 149 (46.1) 52,931 (97.0) 0.3
Oregon 47,132 644 1.4 311 (48.3) 45,613 (96.8) 0.7
Pennsylvania¶ 146,434 2,164 1.5 1,170 (54.1) 140,973 (96.3) 0.8
Puerto Rico 44,773 90 0.2 38 (42.2) 43,902 (98.1) 0.1
Rhode Island 11,442 272 2.4 155 (57.0) 10,977 (95.9) 1.4
South Carolina 60,620 580 1.0 300 (51.7) 58,458 (96.4) 0.5
South Dakota 11,934 75 0.6 41 (54.7) 11,627 (97.4) 0.3
Tennessee 82,211 490 0.6 235 (48.0) 79,616 (96.8) 0.3
Texas 401,977 4,367 1.1 2,054 (47.0) 389,116 (96.8) 0.5
Utah 53,887 533 1.0 272 (51.0) 52,161 (96.8) 0.5
Vermont 6,110 75 1.2 41 (54.7) 5,939 (97.2) 0.7
Virgin Islands 1,687 ** ** ** ** 1,653 (98.0) **
Virginia 105,059 2,014 1.9 1,124 (55.8) 101,140 (96.3) 1.1
Washington 89,313 1,345 1.5 691 (51.4) 86,432 (96.8) 0.8
West Virginia 21,268 124 0.6 61 (49.2) 20,616 (96.9) 0.3
Wisconsin 70,843 642 0.9 339 (52.8) 68,459 (96.6) 0.5
Wyoming 7,881 51 0.6 20 (39.2) 7,640 (96.9) 0.3
Total 4,180,540†† 60,001 1.4 31,575 (52.6) 4,036,029†† (96.5) 0.8
 * In cases of missing residency data, the patient’s state of residency was assigned as the state in which the ART procedure was performed.
 † Source: U.S. natality file, CDC, National Center for Health Statistics. Singleton deliveries reported include infants from both singleton and multiple gestations.
 § Includes infants conceived from ART procedures performed in 2008 and born in 2009, and infants conceived from ART procedures performed in 2009 and born in 
2009. Total ART births exclude nonresidents.
 ¶ A substantial percentage (6%–32%) of residency information was missing for procedures started in these four states.
 ** Data not provided to preserve confidentiality but included in totals.
 †† U.S. births includes nonresidents. 
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TABLE 4. Number, percentage, and proportion of multiple-birth, twins, and triplets (plus) infants born with use of assisted reproductive 








born who are 
multiple-birth§


























bornNo. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Alabama 178 (44.2) 2,160 (3.5) 8.2 160 (39.7) 2,074 (3.3) 7.7 ¶ (4.5) 86 (0.1) 20.9
Alaska 34 (51.5) 359 (3.2) 9.5 34 (51.5) 348 (3.1) 9.8 ¶ (0) ¶ (0.1) 0
Arizona 483 (49.8) 2,593 (2.8) 18.6 426 (43.9) 2,471 (2.7) 17.2 57 (5.9) 122 (0.1) 46.7
Arkansas 68 (37.6) 1,216 (3.1) 5.6 68 (37.6) 1,186 (3.0) 5.7 ¶ (0) 30 (0.1) 0
California 3,566 (47.3) 16,801 (3.2) 21.2 3290 (43.6) 16,126 (3.1) 20.4 276 (3.7) 675 (0.1) 40.9
Colorado 519 (52.6) 2,344 (3.4) 22.1 480 (48.7) 2,215 (3.2) 21.7 39 (4.0) 129 (0.2) 30.2
Connecticut** 591 (41.6) 1,853 (4.8) 31.9 558 (39.3) 1,786 (4.6) 31.2 33 (2.3) 67 (0.2) 49.3
Delaware 66 (34.7) 394 (3.4) 16.8 60 (31.6) 382 (3.3) 15.7 ¶ (3.2) ¶ (0.1) 50.0
District of 
Columbia 106 (35.7) 344 (3.8) 30.8 106 (35.7) 331 (3.7) 32.0 ¶ (0) ¶ (0.1) 0
Federated States 
of Micronesia
¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶
Florida 1,311 (48.7) 7,181 (3.2) 18.3 1,188 (44.1) 6,881 (3.1) 17.3 123 (4.6) 300 (0.1) 41.0
Georgia** 730 (49.2) 4,968 (3.5) 14.7 676 (45.6) 4,798 (3.4) 14.1 54 (3.6) 170 (0.1) 31.8
Guam ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶
Hawaii 146 (50.0) 616 (3.3) 23.7 134 (45.9) 586 (3.1) 22.9 ¶ (4.1) 30 (0.2) 40.0
Idaho 122 (56.2) 696 (2.9) 17.5 116 (53.5) 671 (2.8) 17.3 ¶ (2.8) 25 (0.1) 24.0
Illinois 1,698 (45.5) 6,568 (3.8) 25.9 1,578 (42.3) 6,261 (3.7) 25.2 120 (3.2) 307 (0.2) 39.1
Indiana 338 (49.7) 2,899 (3.3) 11.7 284 (41.8) 2,725 (3.1) 10.4 54 (7.9) 174 (0.2) 31.0
Iowa 217 (42.9) 1,422 (3.6) 15.3 208 (41.1) 1,352 (3.4) 15.4 ¶ (1.8) 70 (0.2) 12.9
Kansas 198 (51.7) 1,324 (3.2) 15.0 186 (48.6) 1,273 (3.1) 14.6 ¶ (3.1) 51 (0.1) 23.5
Kentucky 216 (45.7) 1,887 (3.3) 11.4 204 (43.1) 1,833 (3.2) 11.1 ¶ (2.5) 54 (0.1) 22.2
Louisiana 212 (53.5) 2,104 (3.2) 10.1 182 (46.0) 2,013 (3.1) 9.0 30 (7.6) 91 (0.1) 33.0
Maine ¶ (50.0) 438 (3.3) 4.1 ¶ (50.0) 429 (3.2) 4.2 ¶ (0) ¶ (0.1) 0
Maryland 765 (41.2) 2,923 (3.9) 26.2 714 (38.5) 2,824 (3.8) 25.3 51 (2.7) 99 (0.1) 51.5
Massachusetts** 1,339 (41.1) 3,549 (4.7) 37.7 1,258 (38.6) 3,392 (4.5) 37.1 81 (2.5) 157 (0.2) 51.6
Michigan 787 (50.0) 4,329 (3.7) 18.2 718 (45.6) 4,098 (3.5) 17.5 69 (4.4) 231 (0.2) 29.9
Minnesota 508 (48.9) 2,610 (3.7) 19.5 484 (46.6) 2,505 (3.5) 19.3 24 (2.3) 105 (0.1) 22.9
Mississippi 91 (52.0) 1,570 (3.7) 5.8 76 (43.4) 1,498 (3.5) 5.1 ¶ (8.6) 72 (0.2) 20.8
Missouri 357 (51.1) 2,705 (3.4) 13.2 324 (46.4) 2,532 (3.2) 12.8 33 (4.7) 173 (0.2) 19.1
Montana 43 (46.7) 369 (3.0) 11.7 40 (43.5) 366 (3.0) 10.9 ¶ (3.3) ¶ (0.0) 100.0
Nebraska 115 (44.7) 1,004 (3.7) 11.5 112 (43.6) 948 (3.5) 11.8 ¶ (1.2) 56 (0.2) 5.4
Nevada 270 (52.0) 1,076 (2.9) 25.1 246 (47.4) 1,032 (2.7) 23.8 24 (4.6) 44 (0.1) 54.5
New Hampshire 136 (48.6) 570 (4.3) 23.9 136 (48.6) 539 (4.0) 25.2 ¶ (0) 31 (0.2) 0
See table footnotes on page 19.
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TABLE 4. (Continued) Number, percentage, and proportion of multiple-birth, twins, and triplets (plus) infants born with use of assisted 








born who are 
multiple-birth§


























bornNo. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
New Jersey 1,851 (48.4) 5,116 (4.6) 36.2 1,704 (44.6) 4,877 (4.4) 34.9 147 (3.8) 239 (0.2) 61.5
New Mexico 101 (48.6) 672 (2.3) 15.0 92 (44.2) 646 (2.2) 14.2 ¶ (4.3) 26 (0.1) 34.6
New York 2,226 (46.0) 5,475 (0.7) 40.7 2,052 (42.4) 4,942 (3.9) 41.5 174 (3.6) 533 (0.4) 32.6
New York City†† 683 (42.6) (3.7) 644 (40.2) 4,572 (3.7) 14.1 39 (2.4)
North Carolina 748 (52.1) 4,485 (3.5) 16.7 664 (46.2) 4,251 (3.4) 15.6 84 (5.8) 234 (0.2) 35.9
North Dakota 53 (52.5) 292 (3.2) 18.2 50 (49.5) 274 (3.0) 18.2 ¶ (3.0) ¶ (0.2) 16.7
Ohio 726 (48.3) 5,107 (3.5) 14.2 660 (43.9) 4,850 (3.3) 13.6 66 (4.4) 257 (0.2) 25.7
Oklahoma 173 (53.6) 1,622 (3.0) 10.7 152 (47.1) 1,536 (2.8) 9.9 21 (6.5) 86 (0.2) 24.4
Oregon 333 (51.7) 1,519 (3.2) 21.9 324 (50.3) 1,471 (3.1) 22.0 ¶ (1.4) 48 (0.1) 18.8
Pennsylvania** 993 (45.9) 5,461 (3.7) 18.2 906 (41.9) 5,216 (3.6) 17.4 87 (4.0) 245 (0.2) 35.5
Puerto Rico 52 (57.8) 871 (1.9) 6.0 40 (44.4) 846 (1.9) 4.7 ¶ (13.3) 25 (0.1) 48.0
Rhode Island 117 (43.0) 465 (4.1) 25.2 114 (41.9) 453 (4.0) 25.2 ¶ (1.1) ¶ (0.1) 25.0
South Carolina 280 (48.3) 2,162 (3.6) 13.0 256 (44.1) 2,072 (3.4) 12.4 24 (4.1) 90 (0.1) 26.7
South Dakota 34 (45.3) 307 (2.6) 11.1 28 (37.3) 293 (2.5) 9.6 ¶ (8.0) ¶ (0.1) 42.9
Tennessee 255 (52.0) 2,595 (3.2) 9.8 234 (47.8) 2,490 (3.0) 9.4 21 (4.3) 105 (0.1) 20.0
Texas 2,310 (52.9) 12,861 (3.2) 18.0 2,130 (48.8) 12,248 (3.0) 17.4 180 (4.1) 613 (0.2) 29.4
Utah 260 (48.8) 1,726 (3.2) 15.1 236 (44.3) 1,659 (3.1) 14.2 24 (4.5) 67 (0.1) 35.8
Vermont 34 (45.3) 171 (2.8) 19.9 34 (45.3) 168 (2.7) 20.2 ¶ (0) ¶ (0) 0
Virgin Islands ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶ ¶
Virginia 890 (44.2) 3,919 (3.7) 22.7 836 (41.5) 3,780 (3.6) 22.1 54 (2.7) 139 (0.1) 38.8
Washington 654 (48.6) 2,881 (3.2) 22.7 618 (45.9) 2,788 (3.1) 22.2 36 (2.7) 93 (0.1) 38.7
West Virginia 62 (50.0) 652 (3.1) 9.5 56 (45.2) 636 (3.0) 8.8 ¶ (4.8) ¶ (0.1) 37.5
Wisconsin 302 (47.0) 2,384 (3.4) 12.7 284 (44.2) 2,288 (3.2) 12.4 18 (2.8) 96 (0.1) 18.8
Wyoming 31 (60.8) 241 (3.1) 12.9 28 (54.9) 232 (2.9) 12.1 ¶ (5.9) ¶ (0.1) 33.3
Total 28,398 (47.3) 139,856§§ (3.3) 20.3 26,208 (43.7) 137,914§§ (3.3) 19.0 2,190 (3.6) 6,365§§ (0.2) 34.4
Abbreviation: Triplets (plus) = triplets and higher order multiple births.
 * In cases of missing residency data, the female patient’s state of residency was assigned as the state in which the ART procedure was performed.
 † ART totals include infants conceived from ART procedures performed in 2008 and born in 2009 and infants conceived from ART procedures performed in 2009 
and born in 2009. Totals exclude nonresidents.
 § Source: U.S. natality file, CDC, National Center for Health Statistics.
 ¶ Data are not provided to preserve confidentiality but are included in totals.
 ** A substantial percentage (6%–32%) of residency information was missing for procedures started in these four states.
 †† New York City total number of multiple birth infants cannot be separated into twins and triplets (plus) and is reported as an aggregate that includes twins and 
higher order multiple births.
 §§ U.S. totals include nonresidents. 
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TABLE 5. Number, percentage, and proportion of infants born with use of assisted reproductive technology (ART), by low birthweight category 

























ART %No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Alabama 130 (32.3) 6,454 (10.3) 2.0 25 (6.2) 1,195 (1.9) 2.1 105 (26.1) 5,259 (8.4) 2.0
Alaska § (19.7) 666 (5.9) 2.0 § (1.5) 113 (1.0) 0.9 § (18.2) 553 (4.9) 2.2
Arizona 327 (33.7) 6,575 (7.1) 5.0 52 (5.4) 1,084 (1.2) 4.8 275 (28.4) 5,491 (5.9) 5.0
Arkansas 50 (27.6) 3,546 (8.9) 1.4 § (4.4) 642 (1.6) 1.2 42 (23.2) 2,904 (7.3) 1.4
California 2,373 (31.4) 35,802 (6.8) 6.6 384 (5.1) 6,064 (1.2) 6.3 1,989 (26.4) 29,738 (5.6) 6.7
Colorado 399 (40.5) 6,007 (8.8) 6.6 47 (4.8) 829 (1.2) 5.7 352 (35.7) 5,178 (7.5) 6.8
Connecticut¶ 391 (27.5) 3,127 (8.0) 12.5 59 (4.2) 555 (1.4) 10.6 332 (23.4) 2,572 (6.6) 13.0
Delaware 50 (26.3) 994 (8.6) 5.0 § (3.7) 214 (1.9) 3.3 43 (22.6) 780 (6.7) 5.5
District of 
Columbia 78 (26.3) 929 (10.3) 8.4 § (2.0) 187 (2.1) 3.2 72 (24.2) 742 (8.2) 9.7
Federated States 
of Micronesia § § § § § § § § § § § § § § §
Florida 918 (34.1) 19,247 (8.7) 4.8 165 (6.1) 3,498 (1.6) 4.7 753 (28.0) 15,749 (7.1) 4.8
Georgia¶ 524 (35.3) 13,190 (9.3) 4.0 110 (7.4) 2,414 (1.7) 4.6 414 (27.9) 10,776 (7.6) 3.8
Guam § § § § § § § § § § § § § § §
Hawaii 111 (38.0) 1,592 (8.4) 7.0 § (6.5) 264 (1.4) 7.2 92 (31.5) 1,328 (7.0) 6.9
Idaho 74 (34.1) 1,541 (6.5) 4.8 § (3.2) 248 (1.0) 2.8 67 (30.9) 1,293 (5.4) 5.2
Illinois 1,147 (30.8) 14,316 (8.4) 8.0 201 (5.4) 2,588 (1.5) 7.8 946 (25.4) 11,728 (6.9) 8.1
Indiana 250 (36.8) 7,225 (8.3) 3.5 49 (7.2) 1,263 (1.5) 3.9 201 (29.6) 5,962 (6.9) 3.4
Iowa 153 (30.2) 2,671 (6.7) 5.7 20 (4.0) 435 (1.1) 4.6 133 (26.3) 2,236 (5.6) 5.9
Kansas 134 (35.0) 3,011 (7.3) 4.5 27 (7.0) 567 (1.4) 4.8 107 (27.9) 2,444 (5.9) 4.4
Kentucky 130 (27.5) 5,141 (8.9) 2.5 22 (4.7) 858 (1.5) 2.6 108 (22.8) 4,283 (7.4) 2.5
Louisiana 163 (41.2) 6,915 (10.6) 2.4 32 (8.1) 1,308 (2.0) 2.4 131 (33.1) 5,607 (8.6) 2.3
Maine § (41.7) 851 (6.3) 1.8 § (8.3) 129 (1.0) 2.3 § (33.3) 722 (5.4) 1.7
Maryland 580 (31.3) 6,836 (9.1) 8.5 108 (5.8) 1,339 (1.8) 8.1 472 (25.4) 5,497 (7.3) 8.6
Massachusetts¶ 847 (26.0) 5,802 (7.7) 14.6 127 (3.9) 1,006 (1.3) 12.6 720 (22.1) 4,796 (6.4) 15.0
Michigan 531 (33.7) 9,799 (8.4) 5.4 121 (7.7) 1,890 (1.6) 6.4 410 (26.0) 7,909 (6.7) 5.2
Minnesota 314 (30.2) 4,604 (6.5) 6.8 60 (5.8) 792 (1.1) 7.6 254 (24.4) 3,812 (5.4) 6.7
Mississippi 70 (40.0) 5,249 (12.2) 1.3 § (6.9) 898 (2.1) 1.3 58 (33.1) 4,351 (10.1) 1.3
Missouri 211 (30.2) 6,393 (8.1) 3.3 33 (4.7) 1,222 (1.5) 2.7 178 (25.5) 5,171 (6.6) 3.4
Montana 27 (29.3) 865 (7.1) 3.1 § (5.4) 125 (1.0) 4.0 22 (23.9) 740 (6.0) 3.0
Nebraska 69 (26.8) 1,922 (7.1) 3.6 § (2.7) 315 (1.2) 2.2 62 (24.1) 1,607 (6.0) 3.9
See table footnotes on page 21.
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TABLE 5. (Continued) Number, percentage, and proportion of infants born with use of assisted reproductive technology (ART), by low birthweight 

























ART %No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
New Hampshire 87 (31.1) 925 (6.9) 9.4 § (6.1) 147 (1.1) 11.6 70 (25.0) 778 (5.8) 9.0
New Jersey 1,255 (32.8) 9,137 (8.3) 13.7 254 (6.6) 1,667 (1.5) 15.2 1,001 (26.2) 7,470 (6.8) 13.4
New Mexico 81 (38.9) 2,416 (8.3) 3.4 § (6.7) 355 (1.2) 3.9 67 (32.2) 2,061 (7.1) 3.3
New York 1,457 (30.1) 20,341 (8.2) 7.2 260 (5.4) 3,767 (1.5) 6.9 1,197 (24.7) 16,574 (6.7) 7.2
New York City** 458 (28.6) 69 (4.3) 389 (24.3)
North Carolina 559 (38.9) 11,454 (9.0) 4.9 112 (7.8) 2,263 (1.8) 4.9 447 (31.1) 9,191 (7.2) 4.9
North Dakota 30 (29.7) 572 (6.4) 5.2 § (7.9) 112 (1.2) 7.1 22 (21.8) 460 (5.1) 4.8
Ohio 459 (30.5) 12,378 (8.5) 3.7 92 (6.1) 2,331 (1.6) 3.9 367 (24.4) 10,047 (6.9) 3.7
Oklahoma 125 (38.7) 4,558 (8.4) 2.7 30 (9.3) 799 (1.5) 3.8 95 (29.4) 3,759 (6.9) 2.5
Oregon 207 (32.1) 2,955 (6.3) 7.0 24 (3.7) 479 (1.0) 5.0 183 (28.4) 2,476 (5.3) 7.4
Pennsylvania¶ 636 (29.4) 12,187 (8.3) 5.2 121 (5.6) 2,347 (1.6) 5.2 515 (23.8) 9,840 (6.7) 5.2
Puerto Rico 43 (47.8) § § § § (7.8) § § § 36 (40.0) § § §
Rhode Island 76 (27.9) 913 (8.0) 8.3 20 (7.4) 193 (1.7) 10.4 56 (20.6) 720 (6.3) 7.8
South Carolina 189 (32.6) 6,047 (10.0) 3.1 36 (6.2) 1,104 (1.8) 3.3 153 (26.4) 4,943 (8.2) 3.1
South Dakota 24 (32.0) 696 (5.8) 3.4 § (13.3) 129 (1.1) 7.8 § (18.7) 567 (4.8) 2.5
Tennessee 181 (36.9) 7,539 (9.2) 2.4 39 (8.0) 1,364 (1.7) 2.9 142 (29.0) 6,175 (7.5) 2.3
Texas 1,712 (39.2) 34,137 (8.5) 5.0 314 (7.2) 5,906 (1.5) 5.3 1,398 (32.0) 28,231 (7.0) 5.0
Utah 195 (36.6) 3,766 (7.0) 5.2 28 (5.3) 550 (1.0) 5.1 167 (31.3) 3,216 (6.0) 5.2
Vermont 19 (25.3) 411 (6.7) 4.6 § (10.7) 67 (1.1) 11.9 § (14.7) 344 (5.6) 3.2
Virgin Islands § § § § § § § § § § § § § § §
Virginia 615 (30.5) 8,779 (8.4) 7.0 119 (5.9) 1,703 (1.6) 7.0 496 (24.6) 7,076 (6.7) 7.0
Washington 428 (31.8) 5,580 (6.2) 7.7 66 (4.9) 862 (1.0) 7.7 362 (26.9) 4,718 (5.3) 7.8
West Virginia 44 (35.5) 1,952 (9.2) 2.3 § (5.6) 313 (1.5) 2.2 37 (29.8) 1,639 (7.7) 2.3
Wisconsin 197 (30.7) 5,027 (7.1) 3.9 42 (6.5) 850 (1.2) 4.9 155 (24.1) 4,177 (5.9) 3.7
Wyoming 24 (47.1) 661 (8.4) 3.6 § (3.9) 90 (1.1) 2.2 22 (43.1) 571 (7.2) 3.9
Total 19,408 (32.3) 336,747†† (8.1) 5.8 3,452 (5.8) 59,917†† (1.4) 5.8 15,953 (26.6) 276,830†† (6.6) 5.8
Abbreviations: LBW = low birthweight, VLBW = very low birthweight, MLBW = moderate low birthweight.
 * In cases of missing residency data, the patient’s state of residency was assigned as the state in which the ART procedure was performed.
 † ART totals include infants conceived from ART procedures performed in 2008 and born in 2009 and infants conceived from ART procedures performed in 2009 
and born in 2009. Totals exclude nonresidents.
 § Data not provided to preserve confidentiality but included in totals, except for the U.S. Virgin Islands, Puerto Rico, and Guam. 
 ¶ A substantial percentage (6%–32%) of residency information was missing for procedures started in these four states.
 ** Data included in totals for New York.
 †† U.S. totals include nonresidents.
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TABLE 6. Number, percentage, and proportion of infants born with use of assisted reproductive technology (ART), by low gestational age 

























ART %No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Alabama 145 (36.0) 9,712 (15.5) 1.5 25 (6.2) 1,727 (2.8) 1.4 120 (29.8) 7,985 (12.8) 1.5
Alaska 25 (37.9) 1,240 (11.0) 2.0 § (1.5) 159 (1.4) 0.6 24 (36.4) 1,081 (9.5) 2.2
Arizona 368 (37.9) 11,821 (12.7) 3.1 52 (5.4) 1,602 (1.7) 3.2 316 (32.6) 10,219 (11.0) 3.1
Arkansas 54 (29.8) 5,189 (13.0) 1.0 § (6.1) 805 (2.0) 1.4 43 (23.8) 4,384 (11.0) 1.0
California 2,405 (31.9) 53,956 (10.2) 4.5 413 (5.5) 7,948 (1.5) 5.2 1,992 (26.4) 46,008 (8.7) 4.3
Colorado 361 (36.6) 7,730 (11.3) 4.7 54 (5.5) 1,154 (1.7) 4.7 307 (31.1) 6,576 (9.6) 4.7
Connecticut¶ 378 (26.6) 3,973 (10.2) 9.5 69 (4.9) 695 (1.8) 9.9 309 (21.7) 3,278 (8.4) 9.4
Delaware 45 (23.7) 1,445 (12.5) 3.1 § (4.2) 267 (2.3) 3.0 37 (19.5) 1,178 (10.2) 3.1
District of 
Columbia 73 (24.6) 1,280 (14.2) 5.7 § (2.7) 265 (2.9) 3.0 65 (21.9) 1,015 (11.2) 6.4
Federated States 
of Micronesia § § § § § § § § § § § § § § §
Florida 941 (35.0) 29,975 (13.5) 3.1 184 (6.8) 4,953 (2.2) 3.7 757 (28.1) 25,022 (11.3) 3.0
Georgia¶ 542 (36.5) 19,407 (13.7) 2.8 105 (7.1) 3,159 (2.2) 3.3 437 (29.5) 16,248 (11.5) 2.7
Guam § § § § § § § § §
Hawaii 113 (38.7) 2,367 (12.5) 4.8 22 (7.5) 383 (2.0) 5.7 91 (31.2) 1,984 (10.5) 4.6
Idaho 83 (38.2) 2,394 (10.1) 3.5 § (5.5) 360 (1.5) 3.3 71 (32.7) 2,034 (8.6) 3.5
Illinois 1,157 (31.0) 21,168 (12.4) 5.5 204 (5.5) 3,570 (2.1) 5.7 953 (25.6) 17,598 (10.3) 5.4
Indiana 272 40 1,0316 (11.9) 2.6 50 (7.4) 1,694 (2.0) 3.0 222 (32.6) 8,622 (9.9) 2.6
Iowa 181 (35.8) 4,467 (11.3) 4.1 20 (4.0) 637 (1.6) 3.1 161 (31.8) 3,830 (9.6) 4.2
Kansas 151 (39.4) 4,609 (11.1) 3.3 32 (8.4) 718 (1.7) 4.5 119 (31.1) 3,891 (9.4) 3.1
Kentucky 157 (33.2) 7,849 (13.6) 2.0 25 (5.3) 1,252 (2.2) 2.0 132 (27.9) 6,597 (11.5) 2.0
Louisiana 180 (45.5) 9,572 (14.7) 1.9 33 (8.3) 1,711 (2.6) 1.9 147 (37.1) 7,861 (12.1) 1.9
Maine § (38.9) 1,334 (9.9) 1.0 § (8.3) 203 (1.5) 1.5 § (30.6) 1,131 (8.4) 1.0
Maryland 553 (29.8) 9,550 (12.7) 5.8 110 (5.9) 1,694 (2.3) 6.5 443 (23.9) 7,856 (10.5) 5.6
Massachusetts¶ 899 (27.6) 8,099 (10.8) 11.1 141 (4.3) 1,276 (1.7) 11.1 758 (23.3) 6,823 (9.1) 11.1
Michigan 546 (34.7) 14,564 (12.4) 3.7 125 (7.9) 2,606 (2.2) 4.8 421 (26.7) 11,958 (10.2) 3.5
Minnesota 350 (33.7) 7,084 (10.0) 4.9 65 (6.3) 1,073 (1.5) 6.1 285 (27.4) 6,011 (8.5) 4.7
Mississippi 81 (46.3) 7,712 (18.0) 1.1 § (4.6) 1,308 (3.0) 0.6 73 (41.7) 6,404 (14.9) 1.1
Missouri 255 (36.5) 9,578 (12.1) 2.7 44 (6.3) 1,552 (2.0) 2.8 211 (30.2) 8,026 (10.2) 2.6
Montana 32 (34.8) 1,331 (10.9) 2.4 § (4.3) 199 (1.6) 2.0 28 (30.4) 1,132 (9.2) 2.5
Nebraska 83 (32.3) 3,096 (11.5) 2.7 § (5.1) 463 (1.7) 2.8 70 (27.2) 2,633 (9.8) 2.7
Nevada 229 (44.1) 5,133 (13.6) 4.5 38 (7.3) 719 (1.9) 5.3 191 (36.8) 4,414 (11.7) 4.3
See table footnotes on page 23.
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TABLE 6. (Continued) Number, percentage, and proportion of infants born with use of assisted reproductive technology (ART), by low gestational 

























ART %No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
New Jersey 1,251 (32.7) 13,188 (12.0) 9.5 275 (7.2) 2,313 (2.1) 11.9 976 (25.5) 10,875 (9.9) 9.0
New Mexico 87 (41.8) 3,572 (12.3) 2.4 § (7.2) 518 (1.8) 2.9 72 (34.6) 3,054 (10.5) 2.4
New York 1,494 (30.9) 14,167 (11.3) 10.5 297 (6.1) 2,467 (2.0) 12.0 1,197 (24.7) 11,700 (9.3) 10.2
New York City** 449 (28.0) 16,062 (13.1) 2.8 75 (4.7) 2,507 (2.0) 3.0 374 (23.3) 13,555 (11.1) 2.8
North Carolina 560 (39.0) 16,494 (13.0) 3.4 122 (8.5) 3,048 (2.4) 4.0 438 (30.5) 13,446 (10.6) 3.3
North Dakota 31 (30.7) 952 (10.6) 3.3 § (5.9) 144 (1.6) 4.2 25 (24.8) 808 (9.0) 3.1
Ohio 485 (32.3) 17,824 (12.3) 2.7 87 (5.8) 3,253 (2.2) 2.7 398 (26.5) 14,571 (10.1) 2.7
Oklahoma 133 (41.2) 7,512 (13.8) 1.8 34 (10.5) 1,159 (2.1) 2.9 99 (30.7) 6,353 (11.6) 1.6
Oregon 199 (30.9) 4,624 (9.8) 4.3 29 (4.5) 643 (1.4) 4.5 170 (26.4) 3,981 (8.4) 4.3
Pennsylvania¶ 668 (30.9) 16,754 (11.4) 4.0 112 (5.2) 3,048 (2.1) 3.7 556 (25.7) 13,706 (9.4) 4.1
Puerto Rico 40 (44.4) 7,895 (17.6) 0.5 § (5.6) 995 (2.2) 0.5 35 (38.9) 6,900 (15.4) 0.5
Rhode Island 79 (29.0) 1,305 (11.4) 6.1 § (5.9) 264 (2.3) 6.1 63 (23.2) 1,041 (9.1) 6.1
South Carolina 200 (34.5) 8,806 (14.5) 2.3 37 (6.4) 1,553 (2.6) 2.4 163 (28.1) 7,253 (12.0) 2.2
South Dakota 23 (30.7) 1,302 (10.9) 1.8 § (14.7) 189 (1.6) 5.8 § (16.0) 1,113 (9.3) 1.1
Tennessee 210 (42.9) 10,630 (12.9) 2.0 41 (8.4) 1,739 (2.1) 2.4 169 (34.5) 8,891 (10.8) 1.9
Texas 1,778 (40.7) 52,650 (13.1) 3.4 333 (7.6) 7,980 (2.0) 4.2 1,445 (33.1) 44,670 (11.1) 3.2
Utah 201 (37.7) 6,092 (11.3) 3.3 31 (5.8) 746 (1.4) 4.2 170 (31.9) 5,346 (9.9) 3.2
Vermont § (21.3) 570 (9.3) 2.8 § (9.3) 93 (1.5) 7.5 § (12.0) 477 (7.8) 1.9
Virgin Islands § § § § § § § § § § § § § § §
Virginia 631 (31.3) 12,002 (11.4) 5.3 141 (7.0) 2,079 (2.0) 6.8 490 (24.3) 9,923 (9.4) 4.9
Washington 457 (34.0) 9,180 (10.3) 5.0 65 (4.8) 1,288 (1.4) 5.0 392 (29.1) 7,892 (8.8) 5.0
West Virginia 44 (35.5) 2,739 (12.9) 1.6 § (3.2) 433 (2.0) 0.9 40 (32.3) 2,306 (10.8) 1.7
Wisconsin 211 (32.9) 7,724 (10.9) 2.7 38 (5.9) 1,225 (1.7) 3.1 173 (26.9) 6,499 (9.2) 2.7
Wyoming 24 (47.1) 883 (11.2) 2.7 § (7.8) 135 (1.7) 3.0 20 (39.2) 748 (9.5) 2.7
Total 20,039†† (33.4)§§ 510,201¶¶ (12.2) 3.9 3,680 (6.1) 82,180¶¶ (2.0) 4.5 16,356 (27.3)§§ 428,021¶¶ (10.2) 3.8
Abbreviations: PTB = preterm birth, VPTB = very preterm birth, MPTB = moderate preterm birth.
 * In cases of missing residency data, the patient’s state of residency was assigned as the state in which the ART procedure was performed.
 † ART totals include infants conceived from ART procedures performed in 2008 and born in 2009, and infants conceived from ART procedures performed in 2009 
and born in 2009. Totals exclude non–residents.
 § Data not provided to preserve confidentiality but included in totals. 
 ¶ A substantial percentage (6%–32%) of residency information was missing for procedures started in these four states.
 ** Data included in totals for New York.
 †† This number excludes nonresidents and missing gestational age. 
 §§ Percentage based on totals excluding nonresidents and missing gestational age.
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